Evidence map›Paper›PMID 38483291›Full record

ArticleNanomedicine (London, England)2024

Revamping the corneal permeability and antiglaucoma therapeutic potential of brinzolamide using transniosomes: optimization,

Rushikesh K Patil, Vaibhavi Srivastava, Rohit Bhawale, Kamatham Pushpa Tryphena, Dharmendra Kumar Khatri, Nandkumar Doijad, Neelesh Kumar Mehra

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomedicine (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rushikesh K PatilPharmaceutical Nanotechnology Research Laboratory, Department of Pharmaceutics, National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad, Telangana, 500037, India.
Vaibhavi SrivastavaPharmaceutical Nanotechnology Research Laboratory, Department of Pharmaceutics, National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad, Telangana, 500037, India.
Rohit BhawalePharmaceutical Nanotechnology Research Laboratory, Department of Pharmaceutics, National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad, Telangana, 500037, India.
Kamatham Pushpa TryphenaDepartment of Biological Sciences, National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad, Telangana, 500037, India.
Dharmendra Kumar KhatriMolecular & Cellular Neuroscience Lab, Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad, Telangana-500037, India.
Nandkumar DoijadDepartment of Biological Sciences, National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad, Telangana, 500037, India.
Neelesh Kumar MehraPharmaceutical Nanotechnology Research Laboratory, Department of Pharmaceutics, National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad, Telangana, 500037, India.ORCID 0000-0001-5275-8065

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CorneaGlaucomaLiposomesPermeabilitySulfonamidesThiazinesAnimalsCarbonic Anhydrase InhibitorsDrug CarriersDrug Delivery SystemsDrug LiberationHumansIntraocular PressureMaleRabbitsbrinzolamideCarbonic Anhydrase InhibitorsDrug CarriersLiposomesSulfonamidesThiazinesbrinzolamideglaucomananotechnologyocular drug-delivery systemtransniosomes

Identifiers

PMID38483291
PMCPMC11221373

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.